Drugmaker Boehringer Settles Marketing Claim for $95 Million

26.10.2012 - Boehringer Ingelheim Pharmaceuticals agreed to pay $95 million to U.S. government agencies to settle civil allegations that it illegally marketed drugs for unapproved uses, the U.S...